These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37501075)

  • 1. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection.
    Fang Q; Yuan Z; Hu H; Zhang W; Wang G; Wang X
    Clin Epigenetics; 2023 Jul; 15(1):119. PubMed ID: 37501075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
    Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
    Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancer.
    Li D; Zhang L; Fu J; Huang H; Liu Y; Zhu L; Sun H; Sun S; Zhang D; Tian T; Wang F; Hu F; Peng X; Li G; Zhao L; Zheng T; Wang X; Cui B; Zhao Y
    Clin Epigenetics; 2022 Aug; 14(1):102. PubMed ID: 35974349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Validation of Methylation Signatures in Circulating Cell-Free DNA for the Detection of Colorectal Cancer.
    Long Z; Gao Y; Han Z; Yuan H; Yu Y; Pei B; Jia Y; Ye J; Shi Y; Zhang M; Zhao Y; Wu D; Wang F
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cell-free DNA methylation-based blood test for colorectal cancer screening in high-risk population: a prospective cohort study.
    Zhao F; Bai P; Xu J; Li Z; Muhammad S; Li D; Zhang Z; Gao Y; Liu Q
    Mol Cancer; 2023 Sep; 22(1):157. PubMed ID: 37770864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer.
    Chen S; Liu T; Bu D; Zhu J; Wang X; Pan Y; Liu Y; Lu ZJ; Wang P
    FASEB J; 2021 Jul; 35(7):e21720. PubMed ID: 34110642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
    Wang W; Zhu X; Zhang X; Lei C; Zeng Z; Lan X; Cui W; Wang F; Xu S; Zhou J; Wu X; Deng H; Li X; Fan J; Ding Y; Huang Z; Liang L
    J Pathol; 2023 Apr; 259(4):376-387. PubMed ID: 36573552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing.
    Li J; Zhou X; Liu X; Ren J; Wang J; Wang W; Zheng Y; Shi X; Sun T; Li Z; Kang A; Tang F; Wen L; Fu W
    Clin Chem; 2019 Jul; 65(7):916-926. PubMed ID: 31010820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Barault L; Amatu A; Siravegna G; Ponzetti A; Moran S; Cassingena A; Mussolin B; Falcomatà C; Binder AM; Cristiano C; Oddo D; Guarrera S; Cancelliere C; Bustreo S; Bencardino K; Maden S; Vanzati A; Zavattari P; Matullo G; Truini M; Grady WM; Racca P; Michels KB; Siena S; Esteller M; Bardelli A; Sartore-Bianchi A; Di Nicolantonio F
    Gut; 2018 Nov; 67(11):1995-2005. PubMed ID: 28982739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer.
    Li DH; Du XH; Liu M; Zhang R
    Cancer Genet; 2021 Apr; 252-253():80-86. PubMed ID: 33444882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA.
    Ruiz-Bañobre J; Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; Alvarez-Castro A; Carreras-Presas M; Brozos-Vazquez E; Vidal-Insua Y; Vazquez-Rivera F; Candamio-Folgar S; Mosquera-Presedo M; Lago-Lestón RM; Muinelo-Romay L; Vázquez-Bueno JÁ; Sanz-Pamplona R; Moreno V; Goel A; Castillo L; Martin AC; Arroyo R; Esteller M; Crujeiras AB; López-López R; Díaz-Lagares A
    Clin Epigenetics; 2022 Jul; 14(1):86. PubMed ID: 35810318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients.
    Ren J; Lu P; Zhou X; Liao Y; Liu X; Li J; Wang W; Wang J; Wen L; Fu W; Tang F
    Clin Chem; 2022 Feb; 68(2):354-364. PubMed ID: 34791072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles.
    Yasui K; Toshima T; Inada R; Umeda Y; Yano S; Tanioka H; Nyuya A; Fujiwara T; Yamada T; Naomoto Y; Goel A; Nagasaka T
    Mol Cancer; 2024 Jan; 23(1):1. PubMed ID: 38172877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
    Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
    Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.